answer text |
<p>Classification of diseases and disorders is achieved through international clinical
and scientific consensus.</p><p> </p><p>The current version of the World Health Organization’s
International Classification of Diseases (ICD10) includes fibromyalgia under ‘Diseases
of the musculoskeletal system and connective tissue’ in the category ‘Other soft tissue
disorders, not elsewhere classified’. ICD-11, which will be presented at the World
Health Assembly in May 2019 for adoption by member states, includes fibromyalgia under
‘General symptoms, signs or clinical findings’ in the category of ‘chronic widespread
pain’.</p><p> </p><p>The Department’s National Institute for Health Research (NIHR)
welcomes funding applications for research into any aspect of human health, including
fibromyalgia. It is not usual practice to ring-fence funds for particular topics or
conditions; applications are subject to peer review and judged in open competition,
with awards being made on the basis of the importance of the topic to patients and
health and care services, value for money and scientific quality. NIHR support for
fibromyalgia research over the last five years includes £1.8 million funding for research
projects and £0.6 million funding for clinical trials through the NIHR Clinical Research
Network. The NIHR has also managed infrastructure supporting fibromyalgia research.
Information on individual projects funded by the NIHR can be found at the following
link:</p><p> </p><p><a href="http://www.journalslibrary.nihr.ac.uk/programmes/" target="_blank">www.journalslibrary.nihr.ac.uk/programmes/</a></p>
|
|